Siemens Healthineers Symbia Intevo SPECT/CT nuclear medicine scanner

Symbia Intevo
SPECT/CT, které zlepší vaši image

Objevte nový klinický rozsah a standard péče vašeho pracoviště pomocí hybridní SPECT/CT technologie Symbia Intevo™.

Features & Benefits

Female patient positioned on Symbia Intevo scanner bed

Move your technology ahead of the rest

Have confidence in knowing that with the improved image quality and localization gained through the addition of CT, you now have the opportunity to offer a new standard of care. With Symbia Intevo, the industry’s highest SPECT sensitivity¹ and finest reconstructed resolution along with high-performance CT come standard on every system. As a result, you have the assurance of knowing every exam is performed with the highest¹ image quality.

Doctor reviewing scans taken on a Symbia Intevo scanner

Achieve satisfaction through efficient results

In just a single examination, Symbia Intevo SPECT/CT imaging provides a more complete picture of your patient’s condition—allowing you to quickly make decisions that result in successful treatment strategies. Shortening the time to reach a sound diagnosis leads to better care as well as a more satisfying experience for all.

Doctor standing in front of Symbia Intevo SPECT/CT scanner

Build your business on better outcomes

Generate the kinds of competitive advantages that come from adopting innovative molecular imaging advancements. The advanced SPECT and CT technologies inherent across the Symbia Intevo family of systems let you expand your imaging services and further distinguish yourself in the eyes of referring physicians, patients, and the medical community through a reputation for providing quick and meaningful result.

Data courtesy of Universitat Wurzburg, Wurzburg, Germany

SPECT/CT helps evaluate for inducible ischemia in a patient with a history of coronary disease

A SPECT/CT myocardial perfusion scan showed no sign of significant stress-induced ischemia or transmural scars, nor inferior and posterior wall attenuation with CTAC. The normal ejection fraction (EF) was 78%.

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy on file

SPECT/CT assists in accurate localization of neuroendocrine tumor metastases

SPECT/CT localizes multiple tracer-avid somatostatin receptor-rich hepatic metastases, thereby helping in accurate localization of lesions and differentiation of lesion from physiological uptake.

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy of Holy Cross Hospital, Fort Lauderdale, Florida, USA

SPECT/CT localizes peri-auricular lymph sentinel node to aid in precise surgical removal

SPECT/CT imaging precisely defines a small peri-auricular sentinel lymph node due to accurate coregistration of anatomical information from the CT, with focal tracer uptake in the sentinel node seen on SPECT, allowing for precise surgical removal.

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy of Holy Cross Hospital, Fort Lauderdale, Florida, USA

SPECT/CT helps characterize liver lesions with correlation of anatomical and functional information

CT shows focal hypodense liver lesions with absence of tracer uptake on SPECT. Correlation of anatomical information of liver lesions by CT and hepatocyte function by SPECT helps characterize the liver cysts.

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy of CHUV de Brest, Brest, France.

^99mTc xSPECT Quant enables robust and reliable measurement of therapeutic effectiveness

xSPECT Quant™ across multiple time points quantifies the decrease of metabolic activity in the bone in a patient with metastases from prostate cancer. In addition, the uptake measured during anti-androgen therapy at the three time points correlated with a decline of prostate-specific antigen (PSA).

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy of CHUV, Nuclear Medicine, Lausanne, Switzerland.

xSPECT Bone and ^99mTc xSPECT Quant demonstrate details of lytic giant-cell tumor in upper fibula

xSPECT Bone™ and xSPECT Quant™ show grossly increased skeletal metabolism in bony mass (SUV_max 91.7) in the upper part of right fibula. The pattern of well-defined focal lytic areas on the CT, with heterogeneous uptake pattern on xSPECT Bone, is strongly suggestive of giant cell tumor of proximal fibula.

Scanner: Symbia Intevo™ SPECT/CT

123I xSPECT Quant enables standardized quantification for appropriate diagnosis in equivocal motion disorders

Data courtesy of CHUV, Nuclear Medicine, Lausanne, Switzerland.

¹²³I xSPECT Quant enables standardized quantification for appropriate diagnosis in equivocal motion disorders

In addition to a visual read of a SPECT/CT study, xSPECT Quant™ using ¹²³I in ¹²³I-Ioflupane enables standardized quantification assessment to aid in diagnosis in equivocal motion disorders.

Scanner: Symbia Intevo™ SPECT/CT

111In-Octreotide imaging with xSPECT Quant allows a more accurate assessment of neuroendocrine tumor (NET)

Data courtesy of University of CHUV, Nuclear Medicine, Lausanne, Switzerland.

¹¹¹In-Octreotide imaging with xSPECT Quant allows a more accurate assessment of neuroendocrine tumor (NET)

xSPECT Quant™ aids in neuroendocrine tumor (NET) assessment with SPECT/CT by determining changes in tumoral and non-tumoral tracer concentration in order to determine tracer retention within lesions and washout in critical organs.

Scanner: Symbia Intevo™ SPECT/CT

Sequential xSPECT Quant studies determine tracer retention in tumor and kidneys for absorbed dose calculation

Data courtesy of Royal North Shore Hospital, Sydney, Australia.

Sequential xSPECT Quant studies determine tracer retention for absorbed dose calculation

Sequential SPECT/CT with xSPECT Quant™, performed at multiple time points, was used to assess renal and tumor absorbed dose. Studies showed significant response of tumor with shrinkage ,as well as significant reduction in uptake, compared to previous study suggesting positive response to radionuclide therapy.

Scanner: Symbia Intevo™ SPECT/CT

SPECT/CT aids in the detection of vertebral and pelvic degenerative and inflammatory skeletal pathology

Data courtesy on file.

SPECT/CT aids in detection of vertebral and pelvic degenerative and inflammatory skeletal pathology

A SPECT/CT study was conducted for evaluation of skeletal pathology. SPECT/CT images confirmed increased radiographic tracer uptake. These findings are consistent with osteitis pubis and degenerative changes of the lower lumbar spine.

Scanner: Symbia Intevo™ SPECT/CT

$xSPECT Bone shows excellent anatomical detail of the carpal bones in a patient with scaphoid fracture$

Data courtesy of Groene Hart Hospital, Gouda, The Netherlands.

xSPECT Bone shows excellent anatomical detail of the carpal bones in patient with scaphoid fracture

xSPECT Bone™ sharply delineates hypermetabolism at the scaphoid articular surface of the scaphoid-trapezium joint, which reflects bone remodeling secondary to adjacent healed scaphoid fracture following trauma.

Scanner: Symbia Intevo™ SPECT/CT

$xSPECT Bone delineates severity and extent of intertrochanteric hip fracture$

Data courtesy of Korea Presbyterian Medical Center, Jeonju, Jeonbuck, Republic of Korea.

xSPECT Bone delineates severity and extent of intertrochanteric hip fracture

A SPECT/CT study to assess the severity and extent of fracture and the status of right femoral head. xSPECT Bone™ sharply delineates the fracture lines, including fragmented bony margins, thereby helping visualize the displaced fragments and their relationship to adjacent soft tissue.

Scanner: Symbia Intevo™ SPECT/CT

Data courtesy of Universitat Wurzburg, Wurzburg, Germany

SPECT/CT helps evaluate for inducible ischemia in a patient with a history of coronary disease

Data courtesy of Holy Cross Hospital, Fort Lauderdale, Florida, USA

SPECT/CT localizes peri-auricular lymph sentinel node to aid in precise surgical removal

Data courtesy of Holy Cross Hospital, Fort Lauderdale, Florida, USA

SPECT/CT helps characterize liver lesions with correlation of anatomical and functional information

Data courtesy of CHUV de Brest, Brest, France.

^99mTc xSPECT Quant enables robust and reliable measurement of therapeutic effectiveness

Data courtesy of CHUV, Nuclear Medicine, Lausanne, Switzerland.

xSPECT Bone and ^99mTc xSPECT Quant demonstrate details of lytic giant-cell tumor in upper fibula

Data courtesy of CHUV, Nuclear Medicine, Lausanne, Switzerland.

¹²³I xSPECT Quant enables standardized quantification for appropriate diagnosis in equivocal motion disorders

Data courtesy of University of CHUV, Nuclear Medicine, Lausanne, Switzerland.

¹¹¹In-Octreotide imaging with xSPECT Quant allows a more accurate assessment of neuroendocrine tumor (NET)

Data courtesy of Royal North Shore Hospital, Sydney, Australia.

Sequential xSPECT Quant studies determine tracer retention for absorbed dose calculation

Data courtesy on file.

SPECT/CT aids in detection of vertebral and pelvic degenerative and inflammatory skeletal pathology

$xSPECT Bone shows excellent anatomical detail of the carpal bones in a patient with scaphoid fracture$

Data courtesy of Groene Hart Hospital, Gouda, The Netherlands.

xSPECT Bone shows excellent anatomical detail of the carpal bones in patient with scaphoid fracture

$xSPECT Bone delineates severity and extent of intertrochanteric hip fracture$

Data courtesy of Korea Presbyterian Medical Center, Jeonju, Jeonbuck, Republic of Korea.

xSPECT Bone delineates severity and extent of intertrochanteric hip fracture

Data courtesy of Universitat Wurzburg, Wurzburg, Germany

SPECT/CT helps evaluate for inducible ischemia in a patient with a history of coronary disease

Technical Specifications

Gantry
Tunnel opening	70 cm
Tunnel length	89 cm
CT
Generator power	50 kW
Rotation time	up to 0.5 s
Tube voltage	80, 110, 130 kv
SPECT
Crystal thickness	3/8” or 5/8”
Detector dimension (FOV)	53.3 x 38.7 cm
Energy range	35-588 keV
System Sensitivity (LEHR at 10 cm)	202 cpm/μCi
Acquisition modes	Static, dynamic, gated, SPECT, gated SPECT, dynamic SPECT, whole-body, whole-body SPECT, SPECT/CT, xSPECT™
Quantitative accuracy	≤ 5%^2,3